Virsik Peter 4
4 · ESSA Pharma Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Virsik Peter
Chief Operating Officer
Transactions
- Sale
Common Shares
2024-02-05$9.25/sh−694$6,420→ 13,328 total - Sale
Common Shares
2024-02-05$10.04/sh−500$5,020→ 13,328 total - Exercise/Conversion
Common Shares
2024-02-05$3.23/sh+500$1,615→ 13,828 total - Exercise/Conversion
Options
2024-02-05−500→ 967,782 totalExercise: $3.23From: 2023-10-07Exp: 2029-10-07→ Common Shares (500 underlying)
Footnotes (2)
- [F1]Reflects a transaction effected pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.